InMode (INMD) Dividends Paid - Common Growth (1y) (2019 - 2026)
InMode (INMD) Dividends Paid - Common Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | 7.09% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 4.98% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 1.23% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 0.00% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -11.74% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 9.25% |
| 10 | InMode | 912.21 Mn | 497.04 Mn | 71.52 Mn | 83.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170.16% |
| Sep 30, 2025 | 53.14% |
| Jun 30, 2025 | 135.05% |
| Mar 31, 2025 | 20.69% |
| Sep 30, 2024 | 23.26% |
| Jun 30, 2024 | -42.45% |
| Mar 31, 2024 | 30.09% |
| Dec 31, 2023 | 48.05% |
| Sep 30, 2023 | 73.57% |
| Jun 30, 2023 | 80.82% |
| Mar 31, 2023 | 108.11% |
| Dec 31, 2022 | 43.15% |
| Sep 30, 2022 | 11.78% |
| Jun 30, 2022 | 43.11% |
| Mar 31, 2022 | -31.17% |
| Dec 31, 2021 | -1.16% |
| Sep 30, 2021 | 0.14% |
| Jun 30, 2021 | -4.62% |
| Mar 31, 2021 | 43.78% |
| Dec 31, 2020 | 54.13% |